• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

Depression App UpLift Raises $1M to Help People Fight Depression

Share:

July 22, 2019

UpLift is the first mobile consumer app for depression to be based on a complete course of Cognitive Behavioral Therapy (CBT). The new round of funding will be used to accelerate UpLift’s development and improve core technology, while also building out newly requested features like an enhanced gamification system, the ability to connect with a coach, and more evidence-based and personalized activities to improve users’ mood.

Cognitive Behavioral Therapy (CBT) Approach to Depression

UpLift includes twelve tailored “Sessions” and a toolkit of homework “Challenges,” all based on CBT, the most evidence-based psychological treatment in existence. Over the last two decades, computer-based CBT programs have shown to be effective in multiple meta-analyses. UpLift drastically improves upon these first-wave programs by being more interactive, more responsive to user needs, and by being the first available as a mobile app directly to consumers.

Pricing/Costs

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

Pricing for UpLift starts at $29.99 monthly or $14.99 a month quarterly at a 50% discount billed in 3-month increments. Users can cancel this account at any time.

Traction/Milestones to Date

To date, over 20,000 people have signed up for UpLift app. A recent pilot study with 120 participants found that users who completed the program had depression scores fall by 50% in one month, with improvements maintained 6 months later.

“These added resources are an important milestone on our mission to help 1 million people overcome depression.” says Eddie Liu, UpLift’s Co-founder and CEO, who is also the creator of MoodTools, an app for depression downloaded by over 1 million people.

Date: 22/07/2019

Source : Healdepressions

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • EnsoData Raises $9M to Accelerate Waveform AI Platform for CliniciansEnsoData Raises $9M to Accelerate Waveform AI Platform for Clinicians
  • Rubicon Research Acquires Impopharma CanadaRubicon Research Acquires Impopharma Canada
  • Caregiving Services Platform Homage Raises Series B Funding from EV GrowthCaregiving Services Platform Homage Raises Series B Funding from EV Growth
  • How Employee-Focused Tech can Help Hospitals Endure the Latest COVID SurgeHow Employee-Focused Tech can Help Hospitals Endure the Latest COVID Surge
  • Top 5 RCM Challenges for Healthcare Executives in the COVID-19 Era and BeyondTop 5 RCM Challenges for Healthcare Executives in the COVID-19 Era and Beyond
  • Transaction Bolsters Carlisle’s Presence in Attractive Medical Device SegmentTransaction Bolsters Carlisle’s Presence in Attractive Medical Device Segment
  • Merck Begins Tender Offer to Acquire Immune DesignMerck Begins Tender Offer to Acquire Immune Design
  • LightForce Orthodontics Secures $50M for Customized, 3D Printed Orthodontic SolutionsLightForce Orthodontics Secures $50M for Customized, 3D Printed Orthodontic Solutions

Trending This Week

  • Pharmaceutical Compliance Software Market 2022 to Showing Impressive Growth By | [no. of Pages: 118] Industry Trends, Share, Size, Top Key Players Analysis and Forecast Research, Shares and Strategies | By Proficient Market Insights
  • Biosimilars Market: Rise in Number of Cancer Patients to Boost Market
  • Biotechnology and Pharmaceutical Services Outsourcing Market Size 2022 Analysis Report By Competitive Vendors in Top Regions and Countries, Production Types, Applications, Growth, Current Trends and Forecast to 2026
  • The Global Wearable Injectors Market Size is Expected to Reach $12.9 Billion By 2028, Rising at a Market Growth of 9.2% CAGR During the Forecast Period
  • Treprostinil Drugs Market – Insights on how Players Have Cemented Their Positions with Disruptive Technologies, Key Players are United Therapeutics, Novartis, and Teva Pharmaceutical Industries Ltd
  • Protect Pharmaceutical Corporation has Acquired Top Notch Software Development Company

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications